The costs of health care: implications for anti-emetic therapy.
Health economists assess new drug innovations to improve choice. Decision-making techniques for cost analysis should include not only direct costs but costs in terms of increased health benefit, reduced mortality and improved quality of life. The use of anti-emetic drugs results in a significant improvement in the quality of life of patients and decision making on the use of anti-emetic drugs should fully evaluate this patient benefit.